Jennifer Morrison Reveals How Her Journey with Migraine is More Than a Headache

Actress Shares Her Migraine Experience as Part of MoreToMigraine.com

FRAZER, Pa.--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. today announced the launch of More To Migraine, a national campaign aimed at raising awareness of migraine and all that comes with it. The campaign features actress and director Jennifer Morrison who is speaking publicly for the first time about the impact migraine has had on her career and busy lifestyle.

“Throughout my career I have played many roles, but migraine sufferer has been the hardest,” said Jennifer Morrison, More To Migraine spokesperson. “My hope is that by sharing my personal experience, I can encourage the nearly 36 million Americans who suffer from migraine to talk to their healthcare provider about how their migraine impacts them.”

Migraine is more than a headache. The National Institute of Neurological Disorders and Stroke defines migraine as recurrent attacks of moderate to severe headache pain that is throbbing or pulsing, worse with physical activity, and often strikes one side of the head. These headaches can be accompanied by sensitivity to light and sound as well as nausea and vomiting. The frequency, severity and characteristics of migraine vary widely among individuals and many people with migraine may deny their condition or feel embarrassed.

“I know firsthand that not all migraines are the same and aren’t just limited to my head. Talking with my doctor helped me better understand my migraine characteristics and triggers,” Morrison said.

MoreToMigraine.com was created to help provide migraine sufferers with information and resources to help them talk with their healthcare provider about their individual migraine experience. The website features:

• Information about migraine triggers and characteristics including throbbing head pain, nausea, vomiting and sensitivity to light and sound.
• Resources to help migraine sufferers talk with their healthcare provider such as Dr. Susan Hutchinson’s “10 Migraine Tips You Don’t Want to Miss.”
• Personal perspectives from fellow migraine sufferers like Jennifer Morrison.

Visit MoreToMigraine.com for information and resources for people suffering from migraine.

Jennifer Morrison and Dr. Susan Hutchinson serve as a paid spokespeople for Teva Pharmaceuticals.

About Jennifer Morrison

Jennifer Morrison is an American actress, director and migraine sufferer. She is known for her roles as Emma Swan in the ABC adventure fantasy series "Once Upon a Time" and Dr. Allison Cameron in "House M.D.", alongside Hugh Laurie. She also portrayed Zoey Pierson, one of Ted Mosby's love interests, in "How I Met Your Mother" and Winona Kirk, mother of James T. Kirk, in "Star Trek." In 2011, Morrison co-starred alongside Joel Edgerton, Tom Hardy and Nick Nolte the film “Warrior.”

About Teva

Teva Pharmaceutical Industries Ltd is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. In addition to being the world’s largest generic medicines producer, Teva has world-leading positions in multiple specialty medicines therapeutic areas. In North America, Teva’s Specialty Medicines business focuses on innovative treatments for disorders of the central nervous system (CNS), including pain, and respiratory diseases, as well as having a strong presence in oncology, women’s health and select, US-only brands. Our focus is on creating new ways of addressing unmet patient needs, by combining drug development capabilities with devices, patient services and technologies. For more information, visit www.tevausa.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160425005195/en/

For Teva Pharmaceutical Industries Ltd.
PR Contacts:
Nancy Leone, 215-284-0213
Michelle Larkin, 610-786-7335
Doris Saltkill, 913-777-3343

Source: Teva Pharmaceutical Industries Ltd.

You May Also Be Interested In

• Senzime publishes annual and sustainability report for 2023
• Coppernico Receives Final Permits to Drill its Sombrero Copper-Gold Project in Southern Peru
• Net Asset Value(s)